Status:
UNKNOWN
Biomarkers of Atrial Fibrillation Complicated With Stroke Based on Proteomics and Metabolomics
Lead Sponsor:
Yue LI
Conditions:
Atrial Fibrillation
Stroke
Eligibility:
All Genders
18+ years
Brief Summary
Thrombus shedding in patients with atrial fibrillation (AF) can lead to cerebral artery embolism. Stroke caused by AF is very dangerous, which not only threatens the life of patients, but also serious...
Eligibility Criteria
Inclusion
- Age 18 years or above
- Admission with atrial fibrillation or clinic visit for atrial fibrillation
- Receive routine anticoagulant therapy;
- Signing the consent form
Exclusion
- Pregnant women;
- Lactating women;
- Severe mitral stenosis;
- Severe impairment of liver function;
- Severe renal insufficiency;
- Thyroid dysfunction requiring treatment.
Key Trial Info
Start Date :
December 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05181787
Start Date
December 20 2021
End Date
December 31 2023
Last Update
January 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yan
Harbin, Heilongjiang, China, 150001